Case Study: Impact of CellPort Software on FDA Audits

This case study describes the use of the CellPort Cell Culture Suite Software-as-a-Service (SaaS) platform with in vitro testing for Biopharmaceutics Classification System (BCS) biowaiver approvals, where the US FDA permits human testing to be replaced by cell-based in vitro testing when determining bioequivalence of a generic drug to its...